u 78517f has been researched along with Hemorrhagic Shock in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Labruto, F; Song, X; Vaage, J; Valen, G | 1 |
| Beuving, LJ; Fleckenstein, AE; Hall, ED; Linseman, KL; Smith, SL | 1 |
2 other study(ies) available for u 78517f and Hemorrhagic Shock
| Article | Year |
|---|---|
Lazaroid U-83836E improves tolerance to hemorrhagic shock and limb ischemia and reperfusion in rats and increases cardiac heat shock protein 72.
Topics: Acid-Base Equilibrium; Animals; Antioxidants; Biomarkers; Blood Pressure; Body Temperature; Chromans; Disease Models, Animal; HSP72 Heat-Shock Proteins; Ischemia; Lower Extremity; Male; Piperazines; Rats; Rats, Sprague-Dawley; Reference Values; Reperfusion Injury; Shock, Hemorrhagic; Water-Electrolyte Balance | 2006 |
Comparison of the efficacy of mechanistically different antioxidants in the rat hemorrhagic shock model.
Topics: Animals; Antioxidants; Chromans; Deferoxamine; Disease Models, Animal; Ibuprofen; Lipid Peroxidation; Male; Oxypurinol; Piperazines; Pregnatrienes; Rats; Rats, Inbred Strains; Shock, Hemorrhagic; Vitamin E; Xanthine Oxidase | 1991 |